1. Home
  2. HVT vs ENTA Comparison

HVT vs ENTA Comparison

Compare HVT & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haverty Furniture Companies Inc.

HVT

Haverty Furniture Companies Inc.

HOLD

Current Price

$27.36

Market Cap

400.9M

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.60

Market Cap

378.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HVT
ENTA
Founded
1885
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.9M
378.0M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
HVT
ENTA
Price
$27.36
$13.60
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
132.7K
195.9K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
6.05%
N/A
EPS Growth
N/A
29.93
EPS
0.77
N/A
Revenue
$758,995,000.00
$102,814,000.00
Revenue This Year
$8.83
$7.76
Revenue Next Year
$8.70
N/A
P/E Ratio
$35.56
N/A
Revenue Growth
4.99
16.48
52 Week Low
$19.90
$7.05
52 Week High
$29.83
$17.15

Technical Indicators

Market Signals
Indicator
HVT
ENTA
Relative Strength Index (RSI) 56.28 50.26
Support Level $25.26 $13.47
Resistance Level $29.83 $13.98
Average True Range (ATR) 0.65 0.67
MACD -0.21 0.05
Stochastic Oscillator 40.46 36.99

Price Performance

Historical Comparison
HVT
ENTA

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: